Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-05-19Clinical Trial Update: Galantamine for Cognition in People With Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating galantamine for cognitive improvement in people with schizophrenia or schizoaffective disorder has complet…
-
CLINICAL_TRIALS research · 2009-05-18Clinical Trial Update: In-Patient Study In Schizophrenic Patients [Phase 1]
A Phase 1 in-patient trial for schizophrenia sponsored by GlaxoSmithKline has completed.
-
CLINICAL_TRIALS trial_result · 2009-05-15Clinical Trial Update: The Effects of Nicotine Withdrawal on Reward Responsivity in Schizophrenia [Phase 4]
A Phase 4 clinical trial examining how nicotine withdrawal affects reward responsivity in individuals with schizophrenia or schizoaffective …
-
CLINICAL_TRIALS trial_result · 2009-05-15Clinical Trial Update: Complex Problem Solving Training in Schizophrenic Patients [NA]
A Heidelberg University trial assessing complex problem solving training for patients with schizophrenia and schizoaffective disorder; the s…
-
FDA approval · 2009-05-06FDA Approved: FANAPT — Original Application (Vanda Pharmaceuticals Inc.)
FDA approved FANAPT (iloperidone) under the original application by Vanda Pharmaceuticals Inc. for the treatment of schizophrenia. This entr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-05-05Clinical Trial Update: Effect of Add-on Citalopram to Risperidone on Negative Symptoms in Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating add-on citalopram to risperidone for improving negative symptoms in schizophrenia has completed.
-
FDA approval · 2009-04-30FDA Approved: PERPHENAZINE — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for Perphenazine from Endo USA, Inc., resulting in an approved update to the product labeling.
-
FDA approval · 2009-04-30FDA Approved: RISPERIDONE — Original Application (Par Health USA, LLC)
FDA approves Par Health USA, LLC's original application for a generic risperidone product, expanding access to the standard indications for …
-
CLINICAL_TRIALS trial_result · 2009-04-29Clinical Trial Update: Quetiapine Related Neurochemical Changes as Measured by Magnetic Resonance Spectroscopy in Schizophrenia [Phase 4]
This Phase 4 clinical trial evaluated changes in brain neurochemistry in schizophrenia patients treated with quetiapine, using magnetic reso…
-
CLINICAL_TRIALS research · 2009-04-23Clinical Trial Update: Functional Brain Activation Patterns in Schizophrenia, Measured Before and After Treatment
This completed clinical trial from UMC Utrecht investigated functional brain activation patterns in individuals with schizophrenia before an…
-
CLINICAL_TRIALS trial_result · 2009-04-23Clinical Trial Update: Effectiveness of Anti-Psychotic in GPs Setting
A completed clinical trial in general practice settings evaluated the effectiveness of an antipsychotic for schizophrenia and bipolar disord…
-
FDA approval · 2009-04-08FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Clozapine submitted by Mylan Pharmaceuticals Inc. The action confirms regulatory clearance f…
-
CLINICAL_TRIALS trial_result · 2009-04-01Clinical Trial Update: Pilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (Seroquel IR) in Controlling Agitation and Aggressive Symptoms in the Acute Treatment of Patients With Schizophrenia [Phase 4]
Phase 4 pilot study assessing the efficacy and safety of quetiapine fumarate immediate-release (Seroquel IR) for controlling agitation and a…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia [Phase 3]
Phase 3 trial evaluating quetiapine fumarate (Seroquel) versus placebo for efficacy and safety in acutely ill patients with schizophrenia; t…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Seroquel® Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With Schizophrenia [Phase 4]
A Phase 4 clinical trial evaluating Seroquel (quetiapine) combined with cognitive remediation therapy added to conventional treatment in pat…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Seroquel STACK Study in Schizophrenic or Schizoaffective Subjects [Phase 3]
The Phase 3 STACK study of quetiapine (Seroquel) for schizophrenia or schizoaffective disorder has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute Schizophrenic [Phase 4]
This Phase 4 clinical trial assesses the efficacy and safety of Seroquel (quetiapine fumarate) as monotherapy for acute schizophrenia.
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Fast Titration in the Treatment of Schizophrenia, Taiwan [Phase 3]
A Phase 3 clinical trial evaluating fast titration for schizophrenia in Taiwan has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus Risperidone [Phase 4]
A Phase 4 trial comparing cognitive function in schizophrenia patients treated with sertindole versus risperidone; the current status of the…
-
FDA approval · 2009-03-23FDA Approved: RISPERIDONE — Original Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved the original application for Risperidone from Jubilant Cadista Pharmaceuticals Inc., enabling generic risperidone to be markete…
-
CLINICAL_TRIALS trial_result · 2009-03-18Clinical Trial Update: Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia [NA]
A completed clinical trial update evaluating neural inhibition as a mechanism of nicotine dependence in people with schizophrenia and relate…
-
CLINICAL_TRIALS trial_result · 2009-03-16Clinical Trial Update: Efficacy and Safety of Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia [Phase 2]
Phase 2 trial evaluating celecoxib as add-on to risperidone versus risperidone alone in schizophrenia. The study has completed and reports e…
-
FDA approval · 2009-03-14FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approves a supplemental application for haloperidol decanoate submitted by Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS research · 2009-03-13Clinical Trial Update: An Adherence Study of Antipsychotic Medication in Outpatients With Schizophrenia or Schizoaffective Disorder
This is a clinical trial update for an adherence study of antipsychotic medication in outpatients with schizophrenia or schizoaffective diso…
-
FDA approval · 2009-03-12FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for Fluphenazine hydrochloride submitted by PAI Holdings, LLC dba PAI Pharma.